• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用1-β-D-阿拉伯呋喃糖基胞嘧啶处理的细胞中酶促DNA甲基化水平升高。

Elevated level of enzymatic DNA methylation in cells treated with 1-beta-D-arabinofuranosylcytosine.

作者信息

Boehm T L, Drahovsky D

出版信息

Cancer Res. 1982 Apr;42(4):1537-40.

PMID:7060025
Abstract

When mouse P815 mastocytoma cells are cultured in the presence of 1-beta-D-arabinofuranosylcytosine (ara-C), a dose-dependent inhibition of cell proliferation and DNA synthesis can be observed. The DNA synthesized in the presence of ara-C is more highly enzymatically methylated than that of controls as measured by conversion of incorporated [14C]deoxycytidine-derived radioactivity into 5-methylcytosines. Analysis of DNAs by means of the bacterial restriction enzyme HpaII and its isoschizomer MspI revealed an aberrant DNA methylation pattern after ara-C treatment. The hypermethylation of DNA persisted also in the cell cycle following the treatment in the absence of ara-C. No such changes in DNA methylation patterns following ara-C treatment were observed in P815/ara-C, a subclone of P815 cells resistant to ara-C.

摘要

当小鼠P815肥大细胞瘤细胞在1-β-D-阿拉伯呋喃糖基胞嘧啶(ara-C)存在的情况下进行培养时,可以观察到细胞增殖和DNA合成受到剂量依赖性抑制。通过将掺入的[14C]脱氧胞苷衍生的放射性转化为5-甲基胞嘧啶来测量,在ara-C存在下合成的DNA比对照的DNA具有更高的酶促甲基化水平。通过细菌限制酶HpaII及其同裂酶MspI对DNA进行分析,结果显示ara-C处理后DNA甲基化模式异常。在不存在ara-C的情况下进行处理后,DNA的高甲基化在细胞周期中仍然持续存在。在对ara-C具有抗性的P815细胞亚克隆P815/ara-C中,未观察到ara-C处理后DNA甲基化模式的此类变化。

相似文献

1
Elevated level of enzymatic DNA methylation in cells treated with 1-beta-D-arabinofuranosylcytosine.用1-β-D-阿拉伯呋喃糖基胞嘧啶处理的细胞中酶促DNA甲基化水平升高。
Cancer Res. 1982 Apr;42(4):1537-40.
2
Induction of deoxycytidine kinase by 5-azacytidine in an HL-60 cell line resistant to arabinosylcytosine.在对阿糖胞苷耐药的HL-60细胞系中5-氮杂胞苷对脱氧胞苷激酶的诱导作用。
Mol Pharmacol. 1991 Feb;39(2):250-7.
3
Increased activation of 1-beta-D-arabinofuranosylcytosine by hydroxyurea in L1210 cells.羟基脲对L1210细胞中1-β-D-阿拉伯呋喃糖基胞嘧啶激活作用的增强。
Cancer Res. 1980 Sep;40(9):3286-92.
4
Elevated transcriptional complexity and decrease in enzymatic DNA methylation in cells treated with L-ethionine.
Cancer Res. 1981 Oct;41(10):4101-6.
5
Reduced methyl group acceptance of 1-beta-D-arabinofuranosylcytosine-containing DNA polymers.含1-β-D-阿拉伯呋喃糖基胞嘧啶的DNA聚合物的甲基基团接受能力降低。
Biochim Biophys Acta. 1988 Sep 7;950(3):366-73. doi: 10.1016/0167-4781(88)90133-9.
6
DNA strand breaks caused by inhibitors of DNA synthesis: 1-beta-D-arabinofuranosylcytosine and aphidicolin.由DNA合成抑制剂导致的DNA链断裂:1-β-D-阿拉伯呋喃糖基胞嘧啶和阿非迪霉素。
Cancer Res. 1982 Oct;42(10):4050-3.
7
Comparison of enzymatic activities of two deoxycytidine kinases purified from cells sensitive (P815) or resistant (P815/ara-C) to 1-beta-D-arabinofuranosylcytosine.从对1-β-D-阿拉伯呋喃糖基胞嘧啶敏感(P815)或耐药(P815/ara-C)的细胞中纯化得到的两种脱氧胞苷激酶的酶活性比较。
Cancer Res. 1978 Apr;38(4):1105-12.
8
Quantitative analysis of the cytokinetic response of KHT tumors in vivo to 1-beta-D-arabinofuranosylcytosine.
Cancer Res. 1982 Aug;42(8):3125-31.
9
Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines.阿糖胞苷脂肪酸衍生物在白血病和实体瘤细胞系中的抗增殖活性及作用机制
Biochem Pharmacol. 2004 Feb 1;67(3):503-11. doi: 10.1016/j.bcp.2003.09.028.
10
Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis.一类新型异吲哚衍生物对核糖核苷酸还原酶的抑制作用:与阿糖胞苷(Ara-C)的药物协同作用及细胞凋亡诱导
Anticancer Res. 1999 May-Jun;19(3A):1625-33.

引用本文的文献

1
Sequential treatment with cytarabine and decitabine has an increased anti-leukemia effect compared to cytarabine alone in xenograft models of childhood acute myeloid leukemia.与单独使用阿糖胞苷相比,阿糖胞苷和地西他滨序贯治疗在儿童急性髓系白血病的异种移植模型中具有更强的抗白血病作用。
PLoS One. 2014 Jan 28;9(1):e87475. doi: 10.1371/journal.pone.0087475. eCollection 2014.
2
Synchronisation by hydroxyurea does not affect the sensitivity of CEM-C7 lymphoblasts to glucocorticoids.羟基脲同步化处理不会影响CEM-C7淋巴母细胞对糖皮质激素的敏感性。
Br J Cancer. 1984 Mar;49(3):363-6. doi: 10.1038/bjc.1984.57.
3
Can cancer chemotherapy enhance the malignant behaviour of tumours?
癌症化疗会增强肿瘤的恶性行为吗?
Cancer Metastasis Rev. 1987;6(4):503-19. doi: 10.1007/BF00047465.
4
Lack of correlation between DNA-methylating activity and appearance of the immunogenic phenotype in clones of a murine lymphoma treated with mutagens.用诱变剂处理的小鼠淋巴瘤克隆中,DNA甲基化活性与免疫原性表型出现之间缺乏相关性。
Cancer Immunol Immunother. 1989;29(2):139-43. doi: 10.1007/BF00199289.
5
Enhanced experimental metastatic capacity of a murine melanoma following pre-treatment with anticancer drugs.抗癌药物预处理后小鼠黑色素瘤的实验性转移能力增强。
Clin Exp Metastasis. 1986 Oct-Dec;4(4):285-92. doi: 10.1007/BF00133593.
6
Modulation of cytosine arabinoside-induced proliferation inhibition by exogenous adenosylmethionine.外源性腺苷甲硫氨酸对阿糖胞苷诱导的增殖抑制的调节作用。
Cancer Chemother Pharmacol. 1991;28(6):484-6. doi: 10.1007/BF00685828.